Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb. 25, 2021—A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Nov. 3, 2020—Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.
Jul. 14, 2020—Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.
Nov. 19, 2019—Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit.
Aug. 8, 2019—Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases.
Feb. 18, 2019—The Meharry-Vanderbilt Community Engaged Research Core will sponsor “Partnering to Help People with Obesity Better Understand Their Surgical Options” on Friday, March 1. The event is scheduled from 8:30 to 10 a.m. at the Metro Public Health Department, Centennial Room B, located at 2500 Charlotte Ave., Nashville.
Nov. 16, 2018—The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC), and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of pilot and feasibility grants in the following areas.
Aug. 23, 2018—New research by Masoud Ghamari-Langroudi and colleagues has revealed that a certain brain protein called MC3R plays a role in causing the body to reset its "ideal" weight.
Aug. 9, 2018—New research by Shari Barkin shows that improving nutrition and increasing opportunities to be more active were insufficient in achieving sustained reduction in childhood obesity in poor neighborhoods.
Jun. 7, 2018—Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.
Apr. 18, 2018—A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger.
Mar. 23, 2018—Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.